• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. EVALUATION OF EFFICACY AND SAFETY OF MISOPROSTOL FOR CERVICALRIPENINGANDINDUCTIONOFLABOURBYTWODIFFERENTROUTES

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

EVALUATION OF EFFICACY AND SAFETY OF MISOPROSTOL FOR CERVICALRIPENINGANDINDUCTIONOFLABOURBYTWODIFFERENTROUTES

    Author

    • Dr. Kavita Chhabra, Dr.Divya Saraswat
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

BACKGROUND: Cervical ripening is one of the methods employed for induction of labour.
Cervicalripening involves the usage of pharmacological agents or other means to soften, efface or
dilate thecervix to increase the likelihood of a vaginal delivery. Induction of labour (IOL) is the
process
ofinitiatingcontractionsinpregnantpersonswhoarecurrentlynotinlabour,tohelpthemachievevaginaldel
ivery within 24 to 48 hours. OBJECTIVE OF THE STUDY: The objective of the study is
tocompare the efficacy and safety of two different routes of regimen of misoprostol for cervical
ripeningand induction of labour. MATERIALS &METHODS: This prospective comparative
study, wasconducted in the Department of Obstetrics and Gynaecology at Adesh Medical College,
for a periodfrom may January 2021 to June 2021. We enrolled 100 patients in our study. We
divided the
patientsintotwogroupsrandomlyintoGroupAandGroupB.GroupAweadministeredmisoprostolvaginal
lyandGroupBsublingually.Thedoseusedforboththegroupswas25μg.RESULTS&CONCLUSIONS:
In our study, we found that there were no statistically significant differences indemographis,
Bishops Score after induction, number of doses required, complications (foetal distress,meconium
stained liquor and hyper stimulation), maternal side effects and neonatal Apgar
Scoresbetweenthetwogroups.Therewerestatisticallyhighlysignificantdifferencesintheneedforoxytoci
naugmentation between the two groups. Oxytocin augmentation was more in group B in patients
ascomparedto patients in group A.

Keywords

  • induction
  • misoprostol
  • Sublingual
  • cervicalripening
  • inductionoflabour
  • XML
  • PDF 90.29 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 87
    • PDF Download: 131
European Journal of Molecular & Clinical Medicine
Volume 9, Issue 3
February 2022
Page 1866-1869
Files
  • XML
  • PDF 90.29 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 87
  • PDF Download: 131

APA

Saraswat, D. K. C. D. (2022). EVALUATION OF EFFICACY AND SAFETY OF MISOPROSTOL FOR CERVICALRIPENINGANDINDUCTIONOFLABOURBYTWODIFFERENTROUTES. European Journal of Molecular & Clinical Medicine, 9(3), 1866-1869.

MLA

Dr. Kavita Chhabra, Dr.Divya Saraswat. "EVALUATION OF EFFICACY AND SAFETY OF MISOPROSTOL FOR CERVICALRIPENINGANDINDUCTIONOFLABOURBYTWODIFFERENTROUTES". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 1866-1869.

HARVARD

Saraswat, D. K. C. D. (2022). 'EVALUATION OF EFFICACY AND SAFETY OF MISOPROSTOL FOR CERVICALRIPENINGANDINDUCTIONOFLABOURBYTWODIFFERENTROUTES', European Journal of Molecular & Clinical Medicine, 9(3), pp. 1866-1869.

VANCOUVER

Saraswat, D. K. C. D. EVALUATION OF EFFICACY AND SAFETY OF MISOPROSTOL FOR CERVICALRIPENINGANDINDUCTIONOFLABOURBYTWODIFFERENTROUTES. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 1866-1869.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus